Elixir Capital Ltd Falls to 52-Week Low of Rs.90.55 Amidst Continued Downtrend

Mar 09 2026 12:23 PM IST
share
Share Via
Elixir Capital Ltd, a Non Banking Financial Company (NBFC), touched a new 52-week low of Rs.90.55 today, marking a significant decline amid a sustained downtrend. The stock has been under pressure for the past week, reflecting ongoing concerns about its financial performance and valuation metrics.
Elixir Capital Ltd Falls to 52-Week Low of Rs.90.55 Amidst Continued Downtrend

Recent Price Movement and Market Context

On 9 March 2026, Elixir Capital Ltd opened with a gap up of 4.62%, reaching an intraday high of Rs.98.45. However, the stock reversed course during the session, hitting its lowest point at Rs.90.55, a drop of 3.77% from the previous close. This intraday low represents the lowest price level the stock has seen in the past 52 weeks. Despite outperforming its sector by 1.53% on the day, the stock has been on a seven-day losing streak, resulting in a cumulative return decline of -10.49% over this period.

Elixir Capital is currently trading below all key moving averages, including the 5-day, 20-day, 50-day, 100-day, and 200-day averages, signalling a persistent bearish trend. This contrasts with the broader Finance/NBFC sector, which has declined by -2.7% over the same timeframe. The broader market environment has also been challenging, with the Sensex opening sharply lower by 1,862.15 points and trading down 2.48% at 76,963.29. The Sensex has recorded a three-week consecutive fall, losing -7.07% in that span, while the INDIA VIX index hit a new 52-week high, indicating elevated market volatility.

Fundamental Performance and Valuation Concerns

Elixir Capital’s financial fundamentals have been under strain, contributing to the stock’s subdued performance. Over the past year, the company’s operating profits have contracted sharply by -89.3%, with a compound annual growth rate (CAGR) of -1.93%. This decline in profitability is reflected in the company’s return on equity (ROE), which stands at a negative 1.0, indicating a lack of value generation for shareholders.

The stock’s valuation remains elevated relative to its peers, trading at a price-to-book value of 0.9 despite its deteriorating fundamentals. This premium valuation has been a point of concern, especially given the company’s weak long-term growth prospects. Over the last 12 months, Elixir Capital has underperformed the market significantly, delivering a negative return of -28.87%, while the Sensex and BSE500 indices have generated positive returns of 3.58% and 6.57%, respectively.

Fundamentals that don't lie! This Small Cap from Trading shows consistent growth and price strength over time. A reliable pick you can truly count on.

  • - Strong fundamental track record
  • - Consistent growth trajectory
  • - Reliable price strength

Count on This Pick →

Quarterly Financial Highlights

Despite the overall negative trend, Elixir Capital reported some positive quarterly results in December 2025 after three consecutive quarters of declines. The company recorded its highest quarterly net sales at Rs.13.31 crores and a PBDIT (Profit Before Depreciation, Interest and Taxes) of Rs.7.37 crores. The operating profit margin relative to net sales also reached a peak of 55.37% during this quarter, indicating some operational efficiency improvements.

However, these quarterly gains have not translated into a sustained recovery in the stock price or broader financial health, as the company continues to face challenges in reversing its longer-term profitability decline.

Shareholding and Market Capitalisation

The majority shareholding in Elixir Capital remains with the promoters, maintaining control over the company’s strategic direction. The stock’s market capitalisation grade is rated at 4, reflecting its mid-tier size within the NBFC sector. The company’s Mojo Score stands at 27.0, with a Mojo Grade of Strong Sell as of 2 April 2025, an upgrade from the previous Sell rating. This grading reflects the ongoing concerns regarding the company’s financial health and valuation metrics.

Holding Elixir Capital Ltd from Non Banking Financial Company (NBFC)? See if there's a smarter choice! SwitchER compares it with peers and suggests superior options across market caps and sectors!

  • - Peer comparison ready
  • - Superior options identified
  • - Cross market-cap analysis

Switch to Better Options →

Comparative Performance and Sector Dynamics

Elixir Capital’s performance over the past year has lagged behind both the broader market and its sector peers. While the BSE500 index has delivered a 6.57% return in the same period, Elixir Capital’s stock has declined by nearly 29%. This underperformance is compounded by the Finance/NBFC sector’s own challenges, which has seen a decline of 2.7% recently, reflecting broader pressures on financial stocks amid volatile market conditions.

The stock’s 52-week high was Rs.146, indicating a substantial drop of approximately 38% from that peak to the current 52-week low of Rs.90.55. This wide price range underscores the volatility and uncertainty surrounding the company’s outlook.

Technical Indicators and Market Sentiment

From a technical perspective, Elixir Capital’s position below all major moving averages signals a bearish momentum. The stock’s inability to sustain levels above these averages suggests continued selling pressure. The broader market’s weakness, as evidenced by the Sensex’s three-week decline and the spike in volatility indices, adds to the cautious environment in which the stock is trading.

Despite a brief gap up at the open today, the stock’s failure to maintain gains and subsequent fall to the 52-week low highlights the prevailing market sentiment and the challenges the company faces in regaining investor confidence.

Summary of Key Metrics

To summarise, Elixir Capital Ltd’s key metrics as of 9 March 2026 are:

  • New 52-week low: Rs.90.55
  • Seven-day return: -10.49%
  • One-year return: -28.87%
  • Price-to-book value: 0.9
  • ROE: -1.0
  • Operating profit CAGR: -1.93%
  • Mojo Score: 27.0 (Strong Sell)
  • Market cap grade: 4

These figures reflect the stock’s current valuation challenges and the subdued financial performance that have contributed to its recent price decline.

{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
Elixir Capital Ltd is Rated Strong Sell
Mar 05 2026 10:10 AM IST
share
Share Via
Elixir Capital Ltd is Rated Strong Sell
Feb 21 2026 10:10 AM IST
share
Share Via
Are Elixir Capital Ltd latest results good or bad?
Feb 13 2026 07:43 PM IST
share
Share Via
Elixir Capital Ltd is Rated Strong Sell
Feb 10 2026 10:10 AM IST
share
Share Via
Elixir Capital Ltd is Rated Strong Sell
Jan 30 2026 10:10 AM IST
share
Share Via
Elixir Capital Ltd is Rated Strong Sell
Jan 19 2026 10:10 AM IST
share
Share Via